Australia and New Zealand have the highest global annual prevalence of use of "ecstasy", where it is mostly used in capsule and crystal form.
In Australia, the use and availability of "ecstasy" declined during the COVID-19 pandemic but have started to increase again in 2023 (while not yet reaching pre-2020 levels).
In New Zealand, the use of "ecstasy" has remained relatively stable at a high level since 2020, apart from a temporary drop coinciding with the COVID-19 pandemic.
